HCA Healthcare, Inc. $HCA Shares Sold by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp

Key Points

• British Columbia Investment Management Corp has reduced its stake in HCA Healthcare by 27.7%, selling 30,728 shares and holding 80,335 shares valued at approximately $27.76 million.
• HCA Healthcare's latest earnings report revealed earnings per share of $6.84, exceeding analysts' expectations by $0.64, with the company reporting total revenues of $18.61 billion for the quarter.
• The firm declared a quarterly dividend of $0.72 per share, with an annualized dividend yield of 0.7%, reflecting a payout ratio of 12.11%.

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 27.7% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 80,335 shares of the company's stock after selling 30,728 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in HCA Healthcare were worth $27,760,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of HCA. Avantax Advisory Services Inc. grew its stake in HCA Healthcare by 0.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after buying an additional 32 shares during the last quarter. Horizon Investments LLC grew its stake in HCA Healthcare by 1.1% during the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after purchasing an additional 33 shares during the last quarter. Catalyst Financial Partners LLC grew its stake in HCA Healthcare by 4.3% during the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after purchasing an additional 36 shares during the last quarter. RWA Wealth Partners LLC grew its stake in HCA Healthcare by 2.0% during the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company's stock valued at $658,000 after purchasing an additional 37 shares during the last quarter. Finally, Moors & Cabot Inc. grew its stake in HCA Healthcare by 4.8% during the 1st quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock valued at $297,000 after purchasing an additional 39 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on the company. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Stephens raised HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Morgan Stanley decreased their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Finally, Wells Fargo & Company decreased their price objective on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $401.83.

HCA Healthcare Price Performance

NYSE HCA traded down $1.05 during trading hours on Tuesday, reaching $401.72. The company's stock had a trading volume of 1,180,566 shares, compared to its average volume of 1,273,427. The firm has a market capitalization of $94.00 billion, a price-to-earnings ratio of 16.89, a P/E/G ratio of 1.27 and a beta of 1.39. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The company's 50-day moving average is $375.19 and its two-hundred day moving average is $355.12.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.